Exchange: NASDAQ·Updated 06:03 PM EDT
HOWL logo

HOWL Werewolf Therapeutics Inc

$0.943
$0.0225
(2.38%)
Today
Closed $0.9663
$0.0233
(2.41%)
After Hours
EarningsOct 30
Mkt Cap$45.87M
Vol487,379.00

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
40

Bearish Sentiment

How do you feel about HOWL?

Advertisement|Remove ads.